Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN)
DiscussionThe POPCORN study provides a unique platform for translational research to determine the mechanism of action of a novel proposed combination immunotherapy for cancer.Trial registrationProspectively registered on Australian New Zealand Clinical Trials Registry (ACTRN12618001121257) on 06/07/2018.
Source: Trials - Category: Research Source Type: clinical trials
More News: Australia Health | Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Immunotherapy | Kidney Cancer | Lung Cancer | Melanoma | Neoadjuvant Therapy | New Zealand Health | Non-Small Cell Lung Cancer | Renal Cell Carcinoma | Research | Skin Cancer | Study | Toxicology | Xgeva